ARTICLE | Company News
Optimer, Memorial Sloan-Kettering Cancer Center deal
October 7, 2002 7:00 AM UTC
Optimer received an exclusive global license for Globo H vaccine from the center to treat breast and prostate cancer. Optimer will oversee marketing of the vaccine, which is in clinical development. O...